Article Details
Retrieved on: 2024-07-03 18:11:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... BioPharma. 1. The clearance will allow GT BioPharma to proceed with a phase 1 trial of GTB-3650, which is under the TriKE ® platform. The study is ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here